Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology. Oculis’ ...

Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON)FDA Breakthrough Therapy and EMA PRIME desi ...

Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic ...

Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention ...

New post-hoc analysis of OCT scans on GCIPL and analysis of responders with improvement of 15 or 30-letter on low-contrast visual acuity (LCVA) from the Phase 2 ACUITY trial with Privosegtor, to be ...

Privosegtor received EMA PRIME designation for optic neuritis, a condition that can cause vision problems and is often linked to multiple sclerosis. This experimental neuroprotective therapy is ...

Patients who were prescribed Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), or other GLP-1 receptor agonist medications to treat type 2 diabetes or for weight loss may be at risk ...

Share on Pinterest Researchers believe that high doses of semaglutide may reduce blood flow to the optic nerve, which could lead to eye stroke. Maria Korneeva/Getty Images A new study has found that ...

Andrew G. Lee, MD, and Drew Carey, MD, discuss how optic disc cupping after optic neuritis reflects nerve and ganglion cell thinning, not disease type, helping distinguish it from glaucoma. Lee is the ...

As the NFL season winds down there are still cards coming out to chase. For those who love the Donruss Optic Football set, it will be released soon. The chrome-oriented release is here for what could ...

Worsening of vision occurred within a few weeks after onset of symptoms in most eyes with nonarteritic anterior ischemic optic neuropathy (NAION) that progressed. Only a past episode in the other eye, ...